Analyst's Rated Stock: CVS Health Corporation (CVS)


The firm has a market cap of $64.94 billion, a price-to-earnings ratio of 10.83, a PEG ratio of 0.78 and a beta of 1.12. Looking back over the last month, shares have moved -0.06%. CVS Health Corporation (NYSE:CVS) has risen 3.17% since January 17, 2018 and is uptrending. Moving averages are considered to be lagging indicators that simply take the average price of a stock over a certain period of time. The institutional investor held 5.85M shares of the medical and nursing services company at the end of 2018Q3, valued at $475.89 million, up from 5.52 million at the end of the previous reported quarter. Moving averages based on shorter time spans more closely reflect the underlying current trend, but they are also more sensitive to the volatility of the markets, which can generate many false signals. The stock was sold at an average price of $82.00, for a total transaction of $1,166,778.00. About 7,422 shares traded. CVS outperformed the S&P 500 by 3.17%.

Since August 27, 2018, it had 0 insider buys, and 7 sales for $18.41 million activity. The Missouri-based First Heartland Consultants has invested 0.78% in CVS Health Corporation (NYSE:CVS). The insider Hourican Kevin sold $642,300. On Monday, October 1 Bisaccia Lisa also sold $1.72 million worth of CVS Health Corporation (NYSE:CVS). Over the last 90 days, insiders have sold 205,756 shares of company stock valued at $14,668,815. More interesting news about CVS Health Corporation (NYSE:CVS) were released by: and their article: "Judge denies shutdown-based request for stay of Aetna-CVS case - Seeking Alpha" published on January 12, 2019 as well as's news article titled: "Judge accepts CVS changes for Aetna buy - Seeking Alpha" with publication date: December 24, 2018. The positive are 67%. "Has $344,000 Holdings in CVS Health Corp (CVS)" was originally published by PressOracle and is the sole property of of PressOracle. Four equities research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. Beta can be useful to gauge stock price volatility in relation to the broader market. Goldman Sachs has "Hold" rating and $8700 target. (NASDAQ:LASR) to report earnings on February, 4. $11.49 million worth of CVS Health Corporation (NYSE:CVS) shares were sold by MERLO LARRY J. On Thursday, November 29 Denton David M sold $2.02 million worth of CVS Health Corporation (NYSE:CVS) or 25,159 shares. On Wednesday, November 28 the rating was maintained by J.P. Morgan with "Buy".

Investors sentiment increased to 1.12 in 2018 Q3. That's change of 0.05, from 2018Q2's 1.07. 144 funds acquired stakes and 456 increased stakes. 828.14 million shares or 1.36% more from 816.99 million shares in 2018Q2 were reported. Additionally, 0 have recommended that these shares are an Underperforming investment. CVS Health Corporation (NYSE:CVS) has diverse figures for different time frames; starting from week's performance plunged -6.99% in last five regular trading sessions. Cadence Ltd Liability Co reported 113,779 shares or 0.48% of all its holdings. It also reduced Total Sys Svcs Inc (NYSE:TSS) stake by 6,352 shares and now owns 4,007 shares. Woodstock stated it has 110,421 shares or 1.47% of all its holdings.

The company's net profit margin is 1.6 percent. Gofen Glossberg Limited Liability Corporation Il holds 0.07% or 26,609 shares in its portfolio. Jpmorgan Chase holds 0.27% or 17.70M shs.

Ewan McGregor's daughter Clara denies calling father 'a**hole'
Clara posted a picture of Eve posing in a bikini on a sun lounger with the caption: "my mother, ladies & gentlemen". Ewan reportedly left his wife for his Fargo co-star Mary Elizabeth Winstead .

CVS Health Corporation (NYSE:CVS) traded under umbrella of Healthcare sector, shares decreased -2.45% to trade at $63.74 in the last beat. CVS Corp (NYSE:CVS)'s price to earnings ratio stood at 40.78. During the same period in the prior year, the firm posted $1.50 EPS. The profit will be $2.77B for CVS if $2.14 earnings per share becomes true. Bearing that in mind, this company is experiencing top-line progress, as its year-over-year quarterly revenue has grown by 43.20%. Moreover, Gillespie Robinson And Grimm has 3.35% invested in CVS Health Corporation (NYSE:CVS).

For more CVS Health Corporation (NYSE:CVS) news posted briefly go to:,,, or

Horan Capital Management, which manages about $446.88 million and $543.15 million US Long portfolio, upped its stake in Tencent Holdings Ltd Adr (TCEHY) by 419,467 shares to 421,997 shares, valued at $17.23 million in 2018Q3, according to the filing. The firm owned 100,382 shares of the pharmacy operator's stock after buying an additional 11,675 shares during the quarter. Following the completion of the transaction, the insider now directly owns 496,577 shares in the company, valued at approximately $34,283,676.08. The institutional investor owned 606,061 shares of the pharmacy operator's stock after selling 77,053 shares during the quarter.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.